#United States #Vizient #Mindray #Mahwah #Hepatus

Mindray North America Awarded Vizient's Innovative Technology Designation

Mindray North America, a prominent player in healthcare technology development, has achieved recognition from Vizient, Inc. for its Hepatus-Series Transient Elastography systems. This innovative technology targets liver imaging, a critical area amid rising liver disease concerns, and sets a benchmark for advancements in clinical care.

Vizient, renowned for being the largest provider-driven healthcare performance improvement company in the United States, awarded this designation through a council made up of healthcare professionals. They recognized the Hepatus-Series technology for its potential to significantly enhance patient safety, clinical efficacy, and the operational efficiency of healthcare institutions. This validation highlights the importance of innovation in fostering better healthcare outcomes.

Bill Dwyer, Vice President of Corporate and Strategic Accounts at Mindray, emphasized the company's commitment to medical advancements, stating, "Innovation is the cornerstone of our Hepatus technology." The Hepatus-Series leverages sophisticated imaging techniques, empowering clinicians with precise, real-time quantitative data crucial for evaluating liver health and effectively managing diseases. This integration of advanced workflows with a user-friendly design is a game changer in the realm of liver healthcare.

Kelly Flaharty, Senior Director of Contract Services at Vizient, noted that products worthy of the Innovative Technology designation must exhibit unique qualities that distinguish them from their competitors. Acknowledgments such as this one enhance the visibility of promising new technologies among those involved in healthcare delivery.

The Hepatus-Series, which includes the Hepatus 5 and Hepatus 6 systems, stands out due to its high-resolution imaging capabilities and the ability to provide real-time data acquisition. This allows for unparalleled accuracy in assessing liver tissue conditions and identifying early signs of liver disease, contributing to proactive patient management strategies.

Mindray's dedication to continuous innovation is underscored by the features of the Hepatus-Series, which includes a Living Technology promise, ensuring that healthcare providers benefit from ongoing software updates and comprehensive warranty coverage. This commitment to support and service gives healthcare practitioners peace of mind, allowing them to focus on delivering the highest possible standard of care.

As a leader in medical device solutions, Mindray has been advancing healthcare technologies for over three decades. The company is committed to addressing critical challenges within the healthcare landscape, providing robust solutions in patient monitoring, anesthesia, and ultrasound technologies. Their goal is clear: to make quality healthcare accessible to everyone.

For more information on their products and initiatives, interested parties can visit Mindray's website. Mindray continues to pioneer innovations in medical technology, shaping the future of healthcare and enhancing the lives of patients everywhere.